Telangana DCA Seizes Overpriced Anti-Cancer Medicine In Karimnagar

Hyderabad: Drugs Control Administration officials seized ‘Dacazee 500 Injection’ (Dacarbazine Injection IP 500 mg), during the raids carried out on 11th and 12th July, 2024, at a medical shop located in Karimnagar.

The product Dacarbazine Injection 500 mg sold under brand name ‘Dacazee 500 Injection’ is under price control as per Drugs (Prices Control) Order, 2013 and the price of product shall be in accordance with the ‘Ceiling Price’ fixed by National Pharmaceutical Pricing Authority (NPPA), Government of India.

The product ‘Dacazee 500 Injection’ (Dacarbazine Injection IP 500 mg) of Batch No: 323-294, Mfg. Dt: 04/2023, Exp. Dt: 03/2026, Manufactured by: Zee Laboratories Ltd., Paonta Sahib, 173025, Himachal Pradesh, bears MRP as Rs. 1,250/- for one vial (injection), on the label of the product which is a violation of Drugs (Prices Control) Order, 2013.

The Ceiling price fixed by the Central Government including Wholesale Price Index (WPI) for the product “Dacarbazine Injection 500 mg” is Rs. 518.79/- for one injection (Ceiling Price).

Hence Maximum Retail Price (MRP) i.e. including GST 12 % should not be more than Rs. 581/- for one injection (MRP=Ceiling Price+GST)

The firm overpriced the product. Firm charged an excess of Rs. 668.95/- for one injection which is a violation of the Drugs (Prices Control) Order, 2013, which is more than double the Ceiling Price fixed by the Central Government.

Further investigation shall be carried out and action shall be taken as per the law against all the offenders.

Related Posts

PGIMS recalls drug amid probe into deaths

The PGIMS authorities have directed all departments to immediately stop using a specific batch of injectable Propofol, an anaesthetic drug, and return the available stock to the central store. The…

NPPA list brings little relief: No price cut for 25% cancer drugs

Mumbai: Nearly one in four cancer drug packs in a revised price list issued by the National Pharmaceutical Pricing Authority (NPPA) has seen no reduction in maximum retail price (MRP),…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

PGIMS recalls drug amid probe into deaths

PGIMS recalls drug amid probe into deaths

NPPA list brings little relief: No price cut for 25% cancer drugs

NPPA list brings little relief: No price cut for 25% cancer drugs

Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

For Aakash Healthcare, Community People are Apples of its Eyes

For Aakash Healthcare, Community People are Apples of its Eyes

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Yashoda Medicity: Baby takes a Giant Step in just One Year

Yashoda Medicity: Baby takes a Giant Step in just One Year